What does this research mean for the field?

NOX2 deficiency exacerbates lupus nephritis by activating the NLRP3 inflammasome in neutrophils, a mechanism that can be therapeutically mitigated by IL-1β blockade. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To elucidate the mechanistic role of NOX2-derived reactive oxygen species in lupus nephritis pathogenesis and explore targeted therapies.

August 22, 2026Journal of Biomedical ScienceOpen Access

NOX2 deficiency exacerbates lupus nephritis through activation of NLRP3 inflammasome in neutrophils

View Full Paper

Ask AI

Bookmark

Authors

CWChun‐Hsin Wu FLFang‐Yu Lin MLMiao-Shan Lin

Discussion

Member takes

Overview

Preclinical study demonstrates NOX2 loss worsens lupus nephritis in mice via NLRP3 activation, suggesting IL-1 blockade as a targeted therapy.

Key Points

To elucidate the mechanistic role of NOX2-derived reactive oxygen species in lupus nephritis pathogenesis and explore targeted therapies.
Induced lupus using pristane in Ncf1−/− (NOX2-deficient) and wild-type control mice.
Evaluated renal pathology and characterized immune infiltration via flow cytometry and single-cell RNA sequencing (scRNA-seq).
Assessed therapeutic efficacy of an IL-1 receptor antagonist in ameliorating disease severity in NOX2-deficient mice.
NOX2-deficient mice exhibited significantly exacerbated lupus nephritis severity with elevated serum anti-dsDNA antibody titers and worse renal scores compared to wild-type controls.
scRNA-seq and transcriptomic profiling revealed an expanded, highly inflammatory neutrophil subset characterized by a robust interferon signature and upregulated core NLRP3 inflammasome components.
Treatment with an IL-1 receptor antagonist significantly reduced lupus nephritis disease activity scores in NOX2-deficient mice.

Cite This Study

Wu et al. (2026) studied this question.

synapsesocial.com/papers/6a895effca7ade938187d338 https://doi.org/10.1186/s12929-026-01287-2

View Full Paper

Ask AI

Bookmark

August 22, 2026Journal of Biomedical ScienceOpen Access

NOX2 deficiency exacerbates lupus nephritis through activation of NLRP3 inflammasome in neutrophils

View Full Paper

Ask AI

Bookmark

Authors

CWChun‐Hsin Wu FLFang‐Yu Lin MLMiao-Shan Lin

Discussion

Member takes

Overview

Preclinical study demonstrates NOX2 loss worsens lupus nephritis in mice via NLRP3 activation, suggesting IL-1 blockade as a targeted therapy.

Key Points

To elucidate the mechanistic role of NOX2-derived reactive oxygen species in lupus nephritis pathogenesis and explore targeted therapies.
Induced lupus using pristane in Ncf1−/− (NOX2-deficient) and wild-type control mice.
Evaluated renal pathology and characterized immune infiltration via flow cytometry and single-cell RNA sequencing (scRNA-seq).
Assessed therapeutic efficacy of an IL-1 receptor antagonist in ameliorating disease severity in NOX2-deficient mice.
NOX2-deficient mice exhibited significantly exacerbated lupus nephritis severity with elevated serum anti-dsDNA antibody titers and worse renal scores compared to wild-type controls.
scRNA-seq and transcriptomic profiling revealed an expanded, highly inflammatory neutrophil subset characterized by a robust interferon signature and upregulated core NLRP3 inflammasome components.
Treatment with an IL-1 receptor antagonist significantly reduced lupus nephritis disease activity scores in NOX2-deficient mice.

Cite This Study

Wu et al. (2026) studied this question.

synapsesocial.com/papers/6a895effca7ade938187d338 https://doi.org/10.1186/s12929-026-01287-2

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark